Brian Kotzin

Brian Kotzin

Direttore/Membro del Consiglio presso RIGEL PHARMACEUTICALS, INC.

Patrimonio netto: 85 988 $ in data 30/04/2024

74 anni
Health Technology
Consumer Services
Health Services

Profilo

Brian L.
Kotzin
is currently an Independent Director at Rigel Pharmaceuticals, Inc., a Director at Benaroya Research Institute at Virginia Mason, an Independent Director at Biora Therapeutics, Inc., an Independent Director at Kyverna Therapeutics, Inc., a Director at Genascence Corp., a Non-Executive Director at argenx SE, a Member of the Association of American Physicians, and a Member of the American Society of Clinical Investigation.
Previously, Dr. Kotzin held positions as the Chairman-Immunological Sciences Study Section at the National Institutes of Health, the Director-Autoimmunity Centre of Excellence at the University of Colorado Health Sciences Center, a Director at the American College of Rheumatology, a Director at the Federation of Clinical Immunology Societies, and a Director at Vera Therapeutics, Inc. He also served as the Director & Head-Clinical Immunology at the Autoimmunity Center of Excellence from 1998 to 2004, the VP-Global Clinical Development & Head-Inflammation at Amgen, Inc. from 2004 to 2015, and the Chief Medical Officer & Senior Vice President at Nektar Therapeutics from 2017 to 2023.
Additionally, he was the Chief-Rheumatology Section at the Veterans Administration Medical Center and a Professor at National Jewish Health, Inc.Dr. Kotzin completed his undergraduate studies at the University of Southern California and obtained his doctorate from Stanford University School of Medicine.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
31/01/2024 75 000 ( 0.04% ) 82 500 $ 30/04/2024
01/03/2024 5 746 ( 0.02% ) 3 488 $ 30/04/2024
01/03/2024 0 ( -.--% ) - $ 30/04/2024

Posizioni attive di Brian Kotzin

SocietàPosizioneInizio
RIGEL PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 25/08/2017
BIORA THERAPEUTICS, INC. Direttore/Membro del Consiglio 01/06/2019
KYVERNA THERAPEUTICS, INC. Direttore/Membro del Consiglio 01/08/2019
ARGENX SE Direttore/Membro del Consiglio 07/05/2024
Direttore/Membro del Consiglio -
Corporate Officer/Principal -
American Society of Clinical Investigation Corporate Officer/Principal -
Direttore/Membro del Consiglio -
Tutte le posizioni attive di Brian Kotzin

Precedenti posizioni note di Brian Kotzin

SocietàPosizioneFine
NEKTAR THERAPEUTICS Direttore Tecnico/Scientifico/R&S 17/04/2023
░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -
Vedi nel dettaglio l'esperienza di Brian Kotzin

Formazione di Brian Kotzin

University of Southern California Undergraduate Degree
Stanford University School of Medicine Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Brian Kotzin

Relazioni

100 +

Relazioni di 1° grado

19

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa7
AMGEN INC.

Health Technology

NEKTAR THERAPEUTICS

Health Technology

RIGEL PHARMACEUTICALS, INC.

Health Technology

ARGENX SE

Health Technology

KYVERNA THERAPEUTICS, INC.

Health Technology

VERA THERAPEUTICS, INC.

Health Technology

BIORA THERAPEUTICS, INC.

Health Services

Aziende private9

Health Services

American Society of Clinical Investigation

Commercial Services

Commercial Services

Health Services

Federation of Clinical Immunology Societies

Health Technology

Autoimmunity Center of Excellence

Commercial Services

Vedi le connessioni aziendali